ASVRX
Price
$10.13
Change
-$0.07 (-0.69%)
Updated
Sep 14 closing price
Net Assets
2.79B
RYMVX
Price
$89.75
Change
-$1.05 (-1.16%)
Updated
Sep 14 closing price
Net Assets
6.73M
Interact to see
Advertisement

ASVRX vs RYMVX

ASVRX vs RYMVX Comparison Chart in %
View a ticker or compare two or three
VS
ASVRX vs. RYMVX commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASVRX is a Hold and RYMVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ASVRX has more cash in the bank: 2.79B vs. RYMVX (6.73M). ASVRX pays higher dividends than RYMVX: ASVRX (0.42) vs RYMVX (0.12). ASVRX was incepted earlier than RYMVX: ASVRX (17 years) vs RYMVX (22 years). ASVRX (1.60) and RYMVX (1.59) have similar cost to investors . RYMVX is a more actively managed with annual turnover of: 2930.00 vs. ASVRX (42.00). ASVRX (2500) and RYMVX (2500) have matching initial minimum investment requirements. RYMVX annual gain was more profitable for investors over the last year : 15.76 vs. ASVRX (1.34). RYMVX return over 5 years is better than : 29.41 vs. ASVRX (-3.11).
ASVRXRYMVXASVRX / RYMVX
Total Expense Ratio1.601.54104%
Annual Report Gross Expense Ratio1.601.59101%
Fund Existence17 years22 years-
Gain YTD18.95617.434109%
Front LoadN/A5%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.79B6.73M41,430%
Annual Yield % from dividends0.420.12339%
Returns for 1 year1.3415.769%
Returns for 3 years13.7241.6433%
Returns for 5 years-3.1129.41-11%
Returns for 10 years28.81110.1926%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBIOX29.36N/A
N/A
Fidelity Select Biotechnology
NSNRX52.65N/A
N/A
Neuberger Small Cap Growth R3
ETCHX49.63N/A
N/A
Eventide Healthcare & Life Sciences C
MAIJX22.60N/A
N/A
Morgan Stanley Inst Passport ovrs eq R6
JHCQX11.65N/A
N/A
JHancock Fundamental Equity Inc R6